HomeKTTA • NASDAQ
add
Pasithea Therapeutics Corp
Previous close
$3.38
Day range
$3.17 - $3.38
Year range
$3.17 - $17.40
Market cap
4.05M USD
Avg Volume
28.06K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.00M | -20.71% |
Net income | -3.00M | 16.96% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.84M | 21.64% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.36M | -52.20% |
Total assets | 18.64M | -39.21% |
Total liabilities | 823.98K | -63.92% |
Total equity | 17.81M | — |
Shares outstanding | 1.27M | — |
Price to book | 0.20 | — |
Return on assets | -41.38% | — |
Return on capital | -44.20% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -3.00M | 16.96% |
Cash from operations | -3.12M | -17.54% |
Cash from investing | — | — |
Cash from financing | 4.54M | 217.65% |
Net change in cash | 1.39M | 119.73% |
Free cash flow | -2.05M | -7.03% |
About
Founded
2020
Headquarters
Website
Employees
8
